CDRI (Lucknow), Biotech Desk develop testing kit to detect Omicron variant

Our Bureau Updated - February 02, 2022 at 10:30 PM.

CDRI says the kit can identify Omicron in a quick and cost-effective manner

Kolkata: A healthworker prepares to administer a dose of COVID-19 vaccine to a teenager at a school, amid fear of spread of ‘Omicron’ variant, in Kolkata. | Photo Credit: Swapan Mahapatra

Central Drug Research Institute (CDRI), Luckhnow, which functions under the aegis of the Council of Scientific and Industrial Research of India (CSIR) and Hyderabad-based Biotech Desk Pvt have developed one of the few testing kits to detect Omicron variant. According to the Government, this testing kit can identify Omicron variant in a quick and cost-effective manner. 

“Currently, detection of the Omicron variant depends on tests such as ‘S-gene drop out’ or ‘NextGen sequencing’ of the entire viral genome. This kit developed by CDRI can identify Omicron in a quick, cost-effective manner,” Press Information of Bureau in Maharashtra tweeted. 

Omicron is a highly transmissible variant but with moderate symptoms. According to the Health Ministry, currently the third wave is majorly driven by the Omicron variant. However, Delta variant, which causes more severe symptoms, has not completely faded away from various places in the country. 

India conducted 17.42 lakh Covid tests on Wednesday with the total tests of 73.24 crore done so far. On Wednesday, 1.61 lakh Covid cases were registered in the country with 1,733 deaths in the last 24 hours till 8:00 am. The daily positivity rate and the weekly positivity rate stood at 9.26 per cent and 14.15 per cent respectively.

Published on February 2, 2022 17:00

This is a Premium article available exclusively to our subscribers.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.

Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

You have reached your free article limit.
Subscribe now to and get well-researched and unbiased insights on the Stock market, Economy, Commodities and more...

TheHindu Businessline operates by its editorial values to provide you quality journalism.

This is your last free article.